Our findings are entirely at variance with results previously described by Kristiansen et al., which led them to assess CD24 as a strong independent predictor of recurrence not only for Pca but also for lung, breast, and ovarian cancer [9,29-31]. Here, CD24 is linked to ovarian cancer.